Formulation and Drug Delivery, Combination Drugs

Formulation Development Forum: Abuse-deterrent combination drugs

November 02, 2010

Abuse-deterrent combination drugs represent a niche area in formulation development.

Understanding The Requirements For Effective Nasal Drug Delivery

September 01, 2010

One particularly crucial parameter for nasal sprays is the size of the droplets produced during actuation, which can potentially impact bioavailability.

FDA issues proposed rule on cGMPs for combination drug products

October 02, 2009

Pharmaceutical Technology Europe PTE

The FDA issued a proposed rule to clarify the cGMP requirements applicable to combination products in the Federal Register.

Pharmaceutical Technology Europe

The combination drugs debate: unstable and unpatentable

September 01, 2009

Combination products have been researched and administered for many years, some successfully and others not.

Pharmaceutical Technology Europe

The combination drugs debate: Incompatibility problems can be overcome

September 01, 2009

Combining drugs with synergistic mechanisms of action yields some indisputable benefits; improved efficacy, reduced dosing, enhanced patient compliance, to name just a few.